首頁 › 膽管癌（膽管細胞癌） › 德克薩斯州 › Houston
Houston, TX 的 膽管癌（膽管細胞癌） 臨床試驗
13 項針對 膽管癌（膽管細胞癌） 的研究正在 Houston（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study of PHST001 in Advanced Solid Tumors
招募中1 期
- MD Anderson Cancer Center, Houston
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
招募中1 期
- University of Texas MD Anderson Cancer Center, Houston
- NEXT Houston, Houston
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
招募中1 期
- Baylor College of Medicine, Houston
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
招募中1/2 期
- Next Oncology - Houston, Houston
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
招募中1/2 期
- The University of Texas MD Anderson Cancer Center, Houston
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
招募中2 期
- University of Texas MD Anderson Cancer Center, Houston
Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma
招募中1/2 期
- University of Texas, MD Anderson Cancer Center, Houston
A First in Human Study of PLT012 in Participants With Solid Tumor Cancers
招募中1 期
- MD Anderson Cancer Center, Houston
- NEXT Houston, Houston
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
招募中1/2 期
- MD Anderson Cancer Center, Houston
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
招募中1 期
- The University of Texas MD Anderson Cancer Center, Houston
Molecular Epidemiology of Biliary Tree Cancers
招募中觀察性研究
- M D Anderson Cancer Center, Houston
A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Resectable Intrahepatic Cholangiocarcinoma
招募中2 期
- M D Anderson Cancer Center, Houston
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中觀察性研究
- Massive Bio SYNERGY-AI site, Houston
其他城市的 膽管癌（膽管細胞癌） 試驗
- New York City, NY11 項研究
- Boston, MA8 項研究
- Rochester, MN7 項研究
- Arlington, VA7 項研究
- Los Angeles, CA7 項研究
- Chicago, IL7 項研究
- Columbus, OH6 項研究
- Cleveland, OH6 項研究
- Queens, NY5 項研究
- Edison, NJ5 項研究
- Grand Rapids, MI5 項研究
- Nashville, TN5 項研究
Houston 的其他研究
- 非小細胞肺癌145 項研究
- 乳癌126 項研究
- 癌症（所有類型）121 項研究
- 轉移性癌症104 項研究
- 大腸直腸癌102 項研究
- 卵巢癌89 項研究
- 急性髓系白血病85 項研究
- 肺癌78 項研究
- 前列腺癌76 項研究
- 子宮內膜癌68 項研究
- 胰臟癌61 項研究
- 黑色素瘤59 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。